Miostat Injection, containing 0.01% Carbachol, is an intraocular solution by Alcon Ophthalmic Products, designed to induce miosis during ocular surgery. Supplied in a convenient box of 12 vials, Miostat ensures precise control over intraoperative iris motion for enhanced surgical outcomes.

Uses:

• Intraoperative Miosis: Facilitates pupil constriction during cataract surgery and intraocular lens implantation.

Dosage: Administer 0.5 mL into the anterior chamber of the eye during surgery, under the guidance of a healthcare professional.

CDC Guidelines:

• Employ sterile techniques during administration.
• Use only in a controlled surgical setting.
• Properly dispose of unused solution.

Details and Features:

• Precise Miosis Control: Allows for better surgical manipulation and vision.
• Pack of 12 Vials: Ensures availability for multiple procedures.
• Sterile: Maintains the highest standards for surgical safety.

Mechanism of Action: Carbachol is a cholinergic agonist that stimulates the sphincter muscle of the iris, causing pupil constriction and facilitating surgical procedures by stabilizing iris movement.

Directions:

1. Use aseptic techniques to maintain sterility.
2. Administer 0.5 mL directly into the anterior chamber.
3. Perform under an ophthalmologist's direction during surgery.
4. Monitor patient response closely throughout the procedure.

Warnings:

• For intraocular use only under professional supervision.
• Avoid contact with non-target tissues to prevent unintended effects.
• Monitor for signs of excessive miosis or accommodation spasm.
• Keep out of reach of children.

Side Effects: Possible side effects may include:

• Transient ocular discomfort.
• Increased intraocular pressure post-procedure.
• Rarely, corneal edema or clouding.

Consult an ophthalmologist immediately if adverse effects occur.

Miostat Injection delivers reliable miosis induction for optimized surgical precision, trusted by ophthalmic professionals worldwide.